CN Patent

CN111040015B — 19-去甲-c21取代类固醇衍生物

Assigned to Nanjing Noratech Pharmaceuticals Co ltd · Expires 2022-03-18 · 4y expired

What this patent protects

本发明涉及19‑去甲‑C21取代类固醇衍生物及其药物组合物，以及上述19‑去甲‑C21取代类固醇衍生物或其药物组合物在制备用于预防或治疗中枢神经系统紊乱疾病药物中的用途。

USPTO Abstract

本发明涉及19‑去甲‑C21取代类固醇衍生物及其药物组合物，以及上述19‑去甲‑C21取代类固醇衍生物或其药物组合物在制备用于预防或治疗中枢神经系统紊乱疾病药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN111040015B
Jurisdiction
CN
Classification
—
Expires
2022-03-18
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Noratech Pharmaceuticals Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.